Polycystic ovary syndrome (PCOS) is non-uniformly associated with insulin resistance (IR). We examined IR in women with PCOS.
Methods
Sixty-nine PCOS women were subjected to the insulin suppression test (IST) to determine their steady-state plasma glucose (SSPG) as a direct measure of insulin sensitivity.
Results
SSPG exhibited a multimodal distribution suggesting the existence of subpopulations. The heterogeneous distribution of plasma glucose at 180 min (P = 0.011), with three modes, suggested differences in the plasma glucose level trajectories during the IST. Hence, the population was separated into three groups: (i) (n = 33), subjects with SSPG < or = 152.5 mg/dl, corresponding to the first to fifth deciles; (ii) (n = 29), subjects in the interval 152.5 mg/dl < SSPG < or = 300 mg/dl; (iii) (n = 7), subjects with SSPG > 300 mg/dl, corresponding to the tenth decile. Plasma glucose distributions at 180 min showed differences in their mean values and ranges among groups (P < 0.0001). The trajectories of the groups differed significantly during the IST (P < 0.0001).
Conclusions
insulin sensitivity in our patients exhibited a discontinuous distribution, implying that PCOS is a heterogeneous disorder possessing subpopulations regarding IR.
Vigil, P., Contreras, P., Alvarado, J. L., Godoy, A., Salgado, A. M., & Cortés, M. E. (2007). Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. *Human reproduction (Oxford, England)*, *22*(11), 2974-2980. https://doi.org/10.1093/humrep/dem302
Vigil P, Contreras P, Alvarado JL, Godoy A, Salgado AM, Cortés ME. Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Hum Reprod. 2007;22(11):2974-2980. doi:10.1093/humrep/dem302
Vigil, P., et al. "Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome." *Human reproduction (Oxford, England)*, vol. 22, no. 11, 2007, pp. 2974-2980.
Over the past 20 years, it has been clearly documented that the polycystic ovary syndrome (PCOS) has major metabolic sequelae related to insulin resistance and that insulin resistance plays an importa...
Greff D et al., 2023
Open Access
Reproductive Biology and Endocrinology : RB&E
Background: Metformin is the gold standard insulin sensitizer, which is widely used to treat insulin resistance in polycystic ovary syndrome (PCOS). However, metformin may induce gastrointestinal side...
Nestler JE, 2002Human Reproduction (Oxford, England)
Insulin resistance is a prominent feature of polycystic ovarian syndrome (PCOS), and women with the disorder are at increased risk for the development of other diseases that have been linked to insuli...